• EE287 Cost Effectiveness of Pembrolizumab in Combination with Chemotherapy for the Treatment of Patients with Locally Advanced or Metastatic HER2-Negative Gastric or Gastroesophageal Cancer in Mexico

    Jul 1, 2025, 00:00

  • MT17 Digital Health Interventions and Environmental Sustainability: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • MSR51 Maximizing the Impact of In-Trial Interviews Through AI Assisted Analysis

    Jul 1, 2025, 00:00

  • MT39 Real-World Clinical Outcomes, Healthcare Resource Utilization, and Direct Medical Costs in Atrial Fibrillation Patients Receiving Catheter Ablation in Japan

    Jul 1, 2025, 00:00

  • HSD78 Early Breast Cancer in the US and Germany: A Comparison of Real-world Screening and Treatment

    Jul 1, 2025, 00:00

  • HSD104 Colorectal Cancer Screening Initiation Among Newly Age-Eligible Medicaid-Insured Individuals in Texas

    Jul 1, 2025, 00:00

  • EE408 Healthcare Resource Utilization And Costs Following Disease Progression With First-Line Systemic Therapy In Patients With Advanced Endometrial Cancer in the US

    Jul 1, 2025, 00:00

  • EE351 Cost-Utility Analysis of Sequential Therapy of iCT IRd and DRd strategy for Newly Diagnosed Multiple Myeloma Patients Who are Transplant-Ineligible in China

    Jul 1, 2025, 00:00

  • MSR102 Validation Evidence of Self-Reported Measures for Healthcare Resource Utilization in Adult Populations: A Systematic Review

    Jul 1, 2025, 00:00

  • MSR74 Data Extraction from Full-Text PDFs Using Large Language Models for Systematic Reviews

    Jul 1, 2025, 00:00

  • RWD171 Baseline BMI and HbA1c Trends in US Diabetic Patients Initiating GLP-1 Therapy: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • MSR136 Augmenting Race and Ethnicity in a Real-World Oncology Cohort Using the Bayesian Improved Surname Geocoding Methodology

    Jul 1, 2025, 00:00

  • HSD12 Predictors of Therapeutic Duplication Among Older Adults in the National Social Health in Aging Project

    Jul 1, 2025, 00:00

  • HSD65 Telehealth Use Among Adultswith Sickle Cell Disease in Texas Medicaid Before and During the Covid-19 Pandemic

    Jul 1, 2025, 00:00

  • PCR177 Patient-Reported Outcomes in Indirect Treatment Comparisons: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EE524 Millions in Annual National Savings Could Be Realized From Improving the Quality of Uterotonic Medications in Sub-Saharan Africa

    Jul 1, 2025, 00:00

  • PCR243 Developing a Checklist for Patient Engagement in Rare Disease Value Research

    Jul 1, 2025, 00:00

  • PT24 A Quantitative Exploration of Challenges to the Sustainability of the United States Biosimilar Market

    Jul 1, 2025, 00:00

  • EPH12 Estimating Epidemiological Estimates of Rare Diseases in Reimbursement Submissions to Canada's Drug Agency: A Comparison of Approaches in the Absence of Local Real-World Data

    Jul 1, 2025, 00:00

  • PCR57 Investigating the Potential of Extracting Answers to Health-Related Quality of Life Questionnaires From Patient Community Data

    Jul 1, 2025, 00:00

  • HPR14 A Different Approach to the Overall Survival Conversation: A Bayesian Analysis of Overall Survival Benefits Among Oncology Accelerated Approvals

    Jul 1, 2025, 00:00

  • PCR44 Characterizing the Experience of Excessive Daytime Sleepiness in Patients with Idiopathic Hypersomnia: Implications for Measuring Daytime Sleepiness with the Epworth Sleepiness Scale in a Clinical Trial (NCT05156047)

    Jul 1, 2025, 00:00

  • HSD106 Assessing Infection Prevention Staffing and Resource Allocation Across Single and Multi-Facility Hospitals: A Comparative Analysis

    Jul 1, 2025, 00:00

  • HPR8 Healthcare Across Borders: Changes in Physician Numbers and Spatial Inequalities in Hungary and the DACH Countries (Austria, Germany, Switzerland)

    Jul 1, 2025, 00:00

  • PCR214 Correlation and Predictors of EORTC QLQ-C30 GHS-QoL and EQ-5D VAS in Patients With Advanced NSCLC

    Jul 1, 2025, 00:00

  • EE414 Impact Analysis of Statin Discontinuation on Healthcare Resource Utilization (HCRU) and Cost of Care in Patients With Atherosclerotic Cardiovascular Disease (ASCVD) in the US

    Jul 1, 2025, 00:00

  • PCR30 Perfect Health Reporting on EQ-5D-5L: The Role of Personal, Family and Social Network Illness Experiences

    Jul 1, 2025, 00:00

  • MT22 Hope as a Catalyst: AI-Based Conversational Agents in Mental Health Support

    Jul 1, 2025, 00:00

  • SA14 Economic Systematic Literature of Nirmatrelvir+Ritonavir for the Treatment of Patients With Mild to Moderate COVID-19

    Jul 1, 2025, 00:00

  • EPH139 How is Patient Safety Addressed in Pharmacy Degree Programs in Brazil?

    Jul 1, 2025, 00:00

  • EPH47 Characteristics Correlated with Limited Physical Functioning in US Adults with Arthritis: A Cross-Sectional Database Analysis of the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • EE522 Long-Term Cost-Effectiveness Analysis of Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulin Analogues in Patients With Type 2 Diabetes in China

    Jul 1, 2025, 00:00

  • RWD90 Analysis and Management of Computable Operational Definition (CODef) Concept Variation Based on a Large Real-World Studies Library

    Jul 1, 2025, 00:00

  • P55 Access to Care and Ability to Afford Prescription and Medical Treatment Among Adults With Obesity in the United States

    Jul 1, 2025, 00:00

  • PCR136 Consumer and Healthcare Provided Preferences for Adult Combination COVID-19 and Influenza Vaccines: Results from a Discrete Choice Study in France, Italy and Germany

    Jul 1, 2025, 00:00

  • RWD55 A Large Language Model Approach for Evaluating Real-World Evidence in FDA Approvals

    Jul 1, 2025, 00:00

  • HTA68 Strategic Implications of EU HTAR (JCA and JSC) for Global Biopharma and Biotechs: Navigating Evolving Paradigms in Market Access

    Jul 1, 2025, 00:00

  • MSR104 Revolutionizing Multi-Level Network Meta-Regression: Advancing Analysis With the Package

    Jul 1, 2025, 00:00

  • HTA88 What's Cost Got To Do With It? A Review of Key Issues Related to Costs in Health Technology Assessments in Non-Small-Cell Lung Cancer

    Jul 1, 2025, 00:00

  • CO49 Prognostic or Predictive Factors in Biliary Tract Cancer: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • HPR75 Is the IRA Drug Price Negotiation an Evidence-Based Practice? A Critical Analysis of the Evidence Reviewed by CMS for IRA Drug Price Negotiations and Implications for Future Submissions

    Jul 1, 2025, 00:00

  • PCR45 Rethinking Women's Health: Unpacking the 2024 Women's Health Research Roadmap With a Landscape Review of Clinical Outcome Assessments (COA), Health Agency Recommendations and Drug Label Claims With COA Related to Women's Health

    Jul 1, 2025, 00:00

  • PCR163 Effectiveness of Co-Creation Physical Literacy Intervention on Weight Control and Physical Fitness Among Obese Children: A PreliminaryInvestigation

    Jul 1, 2025, 00:00

  • PCR101 Association of Chronic Conditions and Medication Burden with Patient Preferences for Long-Acting Antiretroviral Therapy in HIV Treatment

    Jul 1, 2025, 00:00

  • RWD35 Real-World Impact Of Recurrence On Overall Survival (OS) In Patients With Unresectable Locally Advanced (LA) Esophageal/Gastroesophageal Junction Cancer (EC/GEJC) Treated With Definitive Chemoradiotherapy (dCRT) In US Community Oncolo ...

    Jul 1, 2025, 00:00

  • MSR126 Data-Based Lumping and Splitting of Treatments in Network Meta-Analysis in the Presence of Heterogeneity: A Flexible Non-Parametric Bayesian Approach

    Jul 1, 2025, 00:00

  • CO95 Comparative Efficacy, Safety, and Tolerability of Xanomeline and Trospium Chloride versus Eight Atypical Antipsychotics for the Acute Treatment of Adults with Schizophrenia - A Network Meta-Analysis

    Jul 1, 2025, 00:00

  • HTA78 Assessing the Acceptance of Single-Arm Trials in Health Technology Appraisals: A Review of NICE, CADTH, HAS, and NCPE Appraisals in 2024

    Jul 1, 2025, 00:00

  • PCR91 Patient Reported Outcomes in BRUIN CLL-321: A Phase 3 Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Jul 1, 2025, 00:00

  • HSD70 Importance of Virtual Access for Mental Health Services: Evidence from ESI Population

    Jul 1, 2025, 00:00

  • CO62 Comparison of Central Venous Access Device Insertion Proportions, Costs and Removal Time Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab in HER2+ Early Breast Cancer Patients

    Jul 1, 2025, 00:00

  • EPH43 The Association Between COVID-19 Vaccination History and the Incidence of COVID-19 and Healthcare Resource Use in Rural Residents in Japan

    Jul 1, 2025, 00:00

  • EE513 Assessing the Economic Impact of Biosimilars in the U.S.: A cost analysis of Infliximab, Trastuzumab, and Rituximab

    Jul 1, 2025, 00:00

  • EE398 Cost Comparison of Osimertinib Plus Chemotherapy Versus Amivantamab Plus Lazertinib for the First-Line Treatment of Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC

    Jul 1, 2025, 00:00

  • PT27 Cost-Effectiveness of Delaying Progression of Alzheimer's Disease with Novel Monoclonal Antibodies: A Societal Perspective

    Jul 1, 2025, 00:00

  • PT3 An Artificial Intelligence (AI)-Assisted Systematic Literature Review (SLR) of the Economic Burden in Metastatic Pancreatic Adenocarcinoma: A Proof-of-Concept Study

    Jul 1, 2025, 00:00

  • EPH33 Tinnitus Risk After XBB.1.5 COVID-19 Vaccination: A Self-Controlled Case Series Study

    Jul 1, 2025, 00:00

  • RWD144 Travel Burden of Beta-Thalassemia Patients Receiving Red Blood Cell Transfusions in the Brazilian Public Healthcare System: A Real-World Study

    Jul 1, 2025, 00:00

  • EE437 Out-of-Pocket Health Care Spending Among Medicare Beneficiaries Before and During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • HTA35 Economic Analysis of an Optical Neonatal Skin Maturity Meter (MOMPN) in Brazilian Newborns

    Jul 1, 2025, 00:00

  • PCR167 Hypertension Medication Use and Primary Medication Non-Adherence Among Postpartum Women

    Jul 1, 2025, 00:00

  • MSR21 Do Lifetables Overestimate Non-Cancer-Specific Survival (NCSS) in Oncology? A Case Study From Treatment-Naïve Advanced Melanoma

    Jul 1, 2025, 00:00

  • EPH19 Changes in Respiratory Medication and Antibiotic Use Among Asthma and COPD Individuals During the Pandemic

    Jul 1, 2025, 00:00

  • P18 Disparities in Antipsychotic Prescribing Among the US Medicare Population

    Jul 1, 2025, 00:00

  • RWD167 Inpatient Hospitalization Trends for COPD in 2018 versus 2021 in United States: A Retrospective Analysis

    Jul 1, 2025, 00:00

  • EE270 Cost-Effectiveness Analysis of Tisagenlecleucel for Third-Line Treatment With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients

    Jul 1, 2025, 00:00

  • HPR139 Understanding Japanese Subsidy Initiatives for Rare, Intractable Diseases

    Jul 1, 2025, 00:00

  • EE348 A Systematic Review of Economic Evaluations of Healthcare Associated Infection Prevention and Control Interventions in Long Term Care Facilities

    Jul 1, 2025, 00:00

  • MSR93 DAGDraw: A Responsive and Modern Directed Acyclic Graph Drawing Tool for Causal Inference and Transportability Analysis

    Jul 1, 2025, 00:00

  • EE280 Clinical and Economic Analysis in Rheumatoid Arthritis Treatment: A Managed Care Experience

    Jul 1, 2025, 00:00

  • Psychometric Evaluation of the Proxy-Reported Pediatric Quality of Life Inventory Generic Core Scales Across the Childhood Lifespan in Australian Children and Adolescents With Specified Health Conditions

    Jul 1, 2025, 00:00

  • HTA46 Fostering the Identification and Dissemination ofHealth Technology Assessment Studies: The Brazilian HTA Database Case Study

    Jul 1, 2025, 00:00

  • CO29 Medication Utilization Post Selective Laser Trabeculoplasty or Minimally Invasive Glaucoma Surgeries in Patients With Open-Angle Glaucoma or Ocular Hypertension: A Systematic Review of Recent Literature

    Jul 1, 2025, 00:00

  • CO40 Real-World Patient Characteristics and Treatment Patterns in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Long-Term Survivorship

    Jul 1, 2025, 00:00

  • PCR53 Redesigning the Care Process to Improve the Experience of Patients with Multiple Sclerosis Throughout the Patient Journey. EMpodera

    Jul 1, 2025, 00:00

  • HTA89 Health Technology Assessment in Saudi Arabia - Expectations for Oncology Product Eligibility Based on Predicate Canadian HTA

    Jul 1, 2025, 00:00

  • EPH51 Trends In Oral JAK Inhibitor And Other Drug Use For Myelofibrosis: A Retrospective Real-World Study

    Jul 1, 2025, 00:00

  • PCR56 Translation and Cultural Adaptation of the Pain Impact Questionnaire (PIQ-6) Among Chronic Pain Patients in Japan

    Jul 1, 2025, 00:00

  • MSR3 Parametric Model Selection: Beyond AIC/BIC in Health Economic Context

    Jul 1, 2025, 00:00

  • PCR205 What Is the Level of Agreement between Family Caregivers and Their Children Living with Rheumatic Disease in Reporting Health-Related Quality of Life?

    Jul 1, 2025, 00:00

  • MSR121 An Evaluation of PhlexNeuron, an Internal, Proprietary Artificial Intelligence (AI) Tool for Systematic Literature Review (SLR) Screening

    Jul 1, 2025, 00:00

  • OP9 Budget Impact Model of Enhanced Lung Cancer Screening With AI/ML Tech-Based Software as a Medical Device (SaMD) on a US Cohort and Private Payer Perspective

    Jul 1, 2025, 00:00

  • Potential Impact of EQ-5D-5L Mapping Function Recently Recommended by the National Institute for Health and Care Excellence on Utility Values and Decision Making

    Jul 1, 2025, 00:00

  • MSR143 Developing a Large Language Model-Based Simulation for PT Committees: Methodology and Inputs for Realistic Dynamics

    Jul 1, 2025, 00:00

  • HTA80 Consistency in Reimbursement Decisions for Pediatric Rare Disease Drugsat Canadian HTA Agencies: CDA Versus INESSS

    Jul 1, 2025, 00:00

  • PCR130 Health-Related Quality of Life (HRQoL) of Large B-cell Lymphoma (LBCL) and Follicular Lymphoma (FL) Patients Treated with Axicabtagene Ciloleucel (Axi-cel) in Clinical Trials and the Real-World: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • HPR117 Racial Disparities in Biomarker Testing Rate, First-Line (1L) Treatment Patterns and Clinical Outcomes Among Real-World Patients in the United States (US) with Advanced or Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Jul 1, 2025, 00:00

  • A Scoping Review of Interventions to Reduce the Environmental Footprint of Healthcare

    Jul 1, 2025, 00:00

  • EE393 Cost-Effectiveness of Umeclidinium/Vilanterol Combination Therapy for Group B COPD Patients

    Jul 1, 2025, 00:00

  • CO16 The Impact of Glucocorticoid (GC) Dose on Clinical Outcomes in Congenital Adrenal Hyperplasia (CAH): A Systematic Literature Review (SLR)

    Jul 1, 2025, 00:00

  • HPR20 Collaborations Between Pharma and Digital Health Startups: Advancing Innovation and Reimbursement in Digital Health Technologies

    Jul 1, 2025, 00:00

  • EPH85 Real-World Temporal and Indication-Specific Variation in Drivers of GLP-1 RA Discontinuation

    Jul 1, 2025, 00:00

  • EPH7 The Impact of Endoscopic Screening Programs for Gastric Cancer in Japan

    Jul 1, 2025, 00:00

  • RWD53 Burden of Illness and Healthcare Resource Utilization (HCRU) for Chronic Obstructive Pulmonary Disease (COPD) in Ontario, Canada

    Jul 1, 2025, 00:00

  • EE286 Cost-Effectiveness of NALIRIFOX As a First-Line Treatment for Metastatic Pancreatic Cancer in Taiwan

    Jul 1, 2025, 00:00

  • MSR33 Automated Extraction of Kaplan-Meier Survival Curves Using Generative Artificial Intelligence and Computer Vision

    Jul 1, 2025, 00:00

  • MT29 Budget Impact Analysis of Continuous Glucose Monitoring with Predictive Alarms for Type 1 Diabetes in Chile (T1D): Perspective of the Explicit Health Guarantees Regime

    Jul 1, 2025, 00:00

  • PCR71 Insights from a Shared-Decision Making Appointment Preparation Process in an Eczema Self-Monitoring Mobile Health App

    Jul 1, 2025, 00:00

  • EE258 Burden of Systemic Light-Chain (AL) Amyloidosis by Mayo Stage: Results From an Electronic Health Record (EHR) Linked To Claims Analysis

    Jul 1, 2025, 00:00

  • CO70 Cannabinoids for Symptom Management in Children and Adolescents with Autism Spectrum Disorder: A systematic Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • EE468 Cost-Effectiveness Analysis of Baricitinib Compared to Standard of Care in Improving Symptoms of Alopecia Areata for the Patients in the U.S. From the Healthcare Payer Perspective

    Jul 1, 2025, 00:00

  • MSR153 Frequently Asked Questions (FAQs): What Are the Risks and Mitigation Strategies in Using Gen-AI in HEOR?

    Jul 1, 2025, 00:00

  • EE485 Economic Evaluations of Preventive Interventions for Self-Harm and Suicide: A Systematic Review

    Jul 1, 2025, 00:00

  • PCR230 Patient-Reported Outcomes From a Phase 3 Study of Givinostat in Patients With Duchenne Muscular Dystrophy

    Jul 1, 2025, 00:00

  • EPH183 Gender-Based Gaps In Access to Tricuspid Valve Interventions In England

    Jul 1, 2025, 00:00

  • HSD87 Chimeric Antigen Receptor T Cell (CAR T) Therapy As Second-Line (2L) Treatment for Patients With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): Therapy Choice and Treatment Barriers Among US Oncologists

    Jul 1, 2025, 00:00

  • HPR65 Early Signals of Inflation Reduction Act Impact on Pharmaceutical Investment and Prioritization Decisions

    Jul 1, 2025, 00:00

  • MSR94 To Bootstrap, or Not to Bootstrap Before Multiple Imputation: That Is the Question

    Jul 1, 2025, 00:00

  • CO7 Progression From Systemic Lupus Erythematosus to Lupus Nephritis: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • EPH154 Racial Differences in Health Status Among Newly Diagnosed Type 2 Diabetes

    Jul 1, 2025, 00:00

  • Use of Real-World Data to Support Economic Evaluations of Tumor-Agnostic Therapies: Challenges Remain

    Jul 1, 2025, 00:00

  • PCR198 Evaluating the Influence of User-Complexity on Individual Preferences for Upper Limb Prosthetic Selection: Measurement Tool Development for a Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • EE409 A Systematic Literature Review of Health Economic Models Structures for Chronic Rhinosinusitis with Nasal Polyps

    Jul 1, 2025, 00:00

  • PCR24 Impact of Herpes Zoster Ophthalmicus on Healthcare Utilization and Patient Reported Outcomes: Results from a Multicenter Cohort Study

    Jul 1, 2025, 00:00

  • RWD80 Presenteeism in Employees with Chronic Conditions: An Analysis Using Linked Claims and Self-Reported Employee Health Risk Assessment Data

    Jul 1, 2025, 00:00

  • EE241 Cost-Savings of Primary Healthcare Nurse Practitioners' Planned Interventions for Reducing Transfers of Patients from Home Care to Emergency Departments in Quebec, Canada

    Jul 1, 2025, 00:00

  • PT2 Survival Analysis in Breast Cancer Patients Treated with Targeted Therapies and Conventional Therapies in the US: A Comparative Real World Study

    Jul 1, 2025, 00:00

  • EPH8 Natural History and Burden of Disease Among Patients With Juvenile GM2 Gangliosidoses in France

    Jul 1, 2025, 00:00

  • HTA25 Assessing Disease Severity: How HTA Bodiea Evaluate Unmet Needs and Influemce Decision-Making

    Jul 1, 2025, 00:00

  • RWD148 Epidemiological Estimates of Interstitial Lung Diseases in Mexico: A Real-World Data Analysis of 2,591,278 Hospital Discharges From the Ministry of Health

    Jul 1, 2025, 00:00

  • EE292 Evaluating the Value of Over-the-Counter Oseltamivir for Influenza: A Cost-Utility Analysis From U.S. Payer and Societal Perspectives

    Jul 1, 2025, 00:00

  • P26 VBA and R to Automate Health Economic Model Programming

    Jul 1, 2025, 00:00

  • MSR141 Reconciling Discrepancies in Results with Different Population-adjusted Indirect Comparison (PAIC) Methods

    Jul 1, 2025, 00:00

  • RWD10 Characterizing Cardiovascular Disease Patients in US Community Hospitals Using InsightsDB

    Jul 1, 2025, 00:00

  • RWD37 Identifying Treatment Patterns for Essential Thrombocythemia Using Real-world Data

    Jul 1, 2025, 00:00

  • HTA7 Use of Health Technology Assessments in Specialty Drug Coverage Decisions by U.S. Commercial Health Plans

    Jul 1, 2025, 00:00

  • EE372 Cost-Effectiveness Analysis of Lenvatinib vs Key Comparators in First-Line Unresectable Hepatocellular Carcinoma in Canada

    Jul 1, 2025, 00:00

  • MSR38 GenAI Goes to ISPOR: Exploratory, Descriptive Analysis of Generative AI Performance for Summarizing and Synthesizing ISPOR Research Abstracts as Sources

    Jul 1, 2025, 00:00

  • EE427 Real-World Long-Term Clinical and Economic Outcomes of Preterm Infants with Neonatal Respiratory Distress Syndrome in the United States

    Jul 1, 2025, 00:00

  • PCR231 Beyond the Numbers: Measuring the Real-Life Impact of Medical Treatments via Patient-Level Modeling

    Jul 1, 2025, 00:00

  • RWD79 Retrospective Analysis of Cannabis Hyperemesis Syndrome (CHS) Using US Electronic Medical Records: Demographics and Clinical Characteristics

    Jul 1, 2025, 00:00

  • RWD14 Estimating Healthcare Resource Utilization and Direct Costs of Chronic Myeloid Leukemia in the Brazilian Public Health System

    Jul 1, 2025, 00:00

  • HPR9 From Data to Actionable Insight: A Collaborative Monitoring E) Initiative Convened by Canada’s Drug Agency (CDA-AMC) - Piloting Plans for Diabetes and Contraception

    Jul 1, 2025, 00:00

  • CO93 Real-World Healthcare Resource Utilization in Patients with Idiopathic Pulmonary Fibrosis initiating Antifibrotic Therapy in the Medicare Fee-For-Service Population

    Jul 1, 2025, 00:00

  • HSD69 Patient Characteristics and Treatment Patterns in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Jul 1, 2025, 00:00

  • EPH102 Changes in the Prevalence of Diabetes Mellitus in Pregnancy : A Nationwide Analysis From Hungary

    Jul 1, 2025, 00:00

  • PCR52 Early Patient-Reported Satisfaction in Patients Initiated on Perfluorohexyloctane for Dry Eye Disease

    Jul 1, 2025, 00:00

  • EPH2 National Assessment of Breast and Cervical Cancer Screening Using National Health Interview Survey

    Jul 1, 2025, 00:00

  • PCR232 Patient's Experience of Ulcerative Colitis: A Conceptual Model Based on Qualitative Interviews

    Jul 1, 2025, 00:00

  • MSR19 An Open-Source LLM Framework For Transparent Data Extraction From Research Papers

    Jul 1, 2025, 00:00

  • RWD127 The Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A cross-Sectional Examination of Emergency Department Visits and Inpatient Stays in US claims

    Jul 1, 2025, 00:00

  • PCR211 Patient, Caregiver, and Physician Perspectives on the Burden of Disease Chronic Refractory Gout and Its Treatment: Concept Elicitation

    Jul 1, 2025, 00:00

  • PCR59 Exploring Patient Preferences for Systemic Treatments in Psoriasis: A Review of the Literature

    Jul 1, 2025, 00:00

  • EE272 Healthcare Resource Utilization in Patients with Type 1 Diabetes with or without Prior Type 2 Diabetes Misdiagnosis: A Study in a U.S. Managed Care Population

    Jul 1, 2025, 00:00

  • EPH5 Disability Progression and Associated Costs in Incident Early-Onset Myasthenia Gravis Patients in France A Longitudinal Cohort Study

    Jul 1, 2025, 00:00

  • CO90 What Does the Pan-Asian Evidence for Malignant Robotic-Assisted Procedures With da Vinci Surgical Systems Say? A systematic Literature Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • EE394 Health Economic Impact of Introducing an Adult-Focused 21-valent PCV in the Canadian Adult Population

    Jul 1, 2025, 00:00

  • HPR34 Time to Access Trends of Pharmaceutical Products in EU4 and UK (2019-2021)

    Jul 1, 2025, 00:00

  • EE385 Seasonal Variation in Incidence and Outcomes of Hospitalizations with Severe Community-Acquired Bacterial Pneumonia in the U.S., 2018-2022

    Jul 1, 2025, 00:00

  • PCR69 Examination of Factors Influencing Colorectal Screening Participation

    Jul 1, 2025, 00:00

  • HPR1 Trends in FDA Approvals of Cardiovascular Drugs from 1980 to 2024

    Jul 1, 2025, 00:00

  • RWD64 Real-Word Data on Long-Term Outcomes Among Adult Patients With Myopericarditis Related Heart Failure

    Jul 1, 2025, 00:00

  • HPR84 Trends in Respiratory Pathogen Testing With Individual Pathogen, Small Panel, or Large Panel Polymerase Chain Reaction (PCR) Tests Before and After the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE) Ended

    Jul 1, 2025, 00:00

  • PCR258 Humanistic Burden in Metastatic Triple-Negative Breast Cancer (mTNBC): A Systematic Literature Review (SLR)

    Jul 1, 2025, 00:00

  • EPH29 Prevalence of Claims-Reported Pruritus in Patients With Primary Biliary Cholangitis Overall and Among Those Treated With Obeticholic Acid

    Jul 1, 2025, 00:00

  • CO78 Clinical and Economic Burden of Non-Obstructive Hypertrophic Cardiomyopathy: A Literature Review

    Jul 1, 2025, 00:00

  • PCR179 Patient's Experience of Crohn's Disease: A Conceptual Model Based on Qualitative Interviews

    Jul 1, 2025, 00:00

  • PCR213 Use of Personalized Migraine Summary Reports in a Symptom Tracking Program to Support Migraine Self-Management

    Jul 1, 2025, 00:00

  • PCR202 An Interim Analysis of the Burden of Influenza Infection on Health-Related Quality of Life and Work Productivity Among Adults in the United States

    Jul 1, 2025, 00:00

  • HPR91 Perceptions of Private Health Insurance Among Households in a Small Island Developing State (SIDS): The Case of Grenada

    Jul 1, 2025, 00:00

  • MSR39 Large Language Model and Contextual Prioritization of Titles and Abstracts for Systematic Review Screening

    Jul 1, 2025, 00:00

  • RWD103 Real-World Biologic Prescribing Patterns and Reasons for Discontinuation in Patients with UC and CD

    Jul 1, 2025, 00:00

  • EE494 Cost-Effectiveness Analysis of Axicabtagene Ciloleucel as a Second-Line Treatment for Diffuse Large B-Cell Lymphoma in China

    Jul 1, 2025, 00:00

  • HPR147 Ongoing Accelerated Approval Trends and What It Means for Patients

    Jul 1, 2025, 00:00

  • HTA1 Pathways to MBS Funding for In-Vitro Diagnostics: Timelines and Success Rates in Australia

    Jul 1, 2025, 00:00

  • MSR79 The Impact of Prior Choice for Between-Study Heterogeneity in Network Meta-Analysis on Model Conclusions

    Jul 1, 2025, 00:00

  • PCR154 Information-seekingbehavior of the Hungarian population regarding colorectal cancer: A Digital Epidemiological Study Using Google TrendsTM

    Jul 1, 2025, 00:00

  • HPR144 Factors Delaying the Public Listing of New Drugs in Canada

    Jul 1, 2025, 00:00

  • RWD48 Impact of Circulating Tumor DNA (ctDNA) Burden Among Patients with Head and Neck Dquamous Cell Carcinoma (HNSCC) - A RWE Analysis

    Jul 1, 2025, 00:00

  • CO84 Hydroxyurea Use and Clinical Outcomes Among Adults with Severe Sickle Cell Disease: A retrospective Cohort Study using Electronic Health Record Data

    Jul 1, 2025, 00:00

  • PT26 Cost-Effectiveness Analysis of Sunvozertinib as a Second-line Treatment for Advanced Non-Small Cell Lung Cancer with EGFR exon20ins Mutation: An Economic Evaluation Based on MAIC

    Jul 1, 2025, 00:00

  • HTA71 The Prevalence of Fractional-Polynomial Network Meta-analyses (fpNMAs) in Supporting Reimbursement Recommendations by Canada's Drug Agency (CDA-AMC)

    Jul 1, 2025, 00:00

  • EE290 Potential Impact of New Strategies of Infant Immunization in the Disease and Economic burden of RSV in Colombia

    Jul 1, 2025, 00:00

  • PT33 Reliability and Validity of EuroQol-5 Dimensions-5 Levels in Patients with Hematologic Malignancies: A Cross-Sectional Study

    Jul 1, 2025, 00:00

  • PCR66 Understanding the Caregiver Experience Through an Exploration of the Literature

    Jul 1, 2025, 00:00

  • HTA10 Patient Voice in Rare Disease Health Technology Assessments: Recent Trends in the Use of Qualitative Research in Reimbursement Submissions to Canada's Drug Agency

    Jul 1, 2025, 00:00

  • EE356 Cost-Effectiveness of Population-Based Risk Assessment and Hereditary Cancer Genetic Testing in Primary Care

    Jul 1, 2025, 00:00

  • HSD59 Disparities in Tardive Dyskinesia Diagnosis and Treatment Among the US Medicare Population

    Jul 1, 2025, 00:00

  • EE472 Cost-effectiveness Analysis of Ferric Carboxymaltose (Renegy®) for the Treatment of Iron Deficiency Anemia During Pregnancy: The Mexican Social Security Institute (IMSS) Perspective

    Jul 1, 2025, 00:00

  • EPH173 Baseline Risk of Hospitalization and Mortality in High-Risk Subgroups of a Nirmatrelvir/Ritonavir Treatment-Eligible Population With Mild-to-Moderate COVID-19 in the United States: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • HPR146 Real-World BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2) Testing Trends by Race for Patients with Metastatic Prostate Cancer (mPC) from 2015 to 2024 in the Community Oncology Setting in the United States (US)

    Jul 1, 2025, 00:00

  • MSR96 GenAI for Critical Appraisal of Evidence for Systematic Literature Reviews (SLRs): A Face-Off between GenAI and Human Reviewers

    Jul 1, 2025, 00:00

  • EE343 Systematic Literature Review of the Economic Burden of Illness in Advanced or Metastatic Non-Small Cell Lung Cancer in First-Line

    Jul 1, 2025, 00:00

  • HPR145 Medicare Spending on Orphan Drugs With Single and Multiple Rare Disease Indications

    Jul 1, 2025, 00:00

  • MSR18 Machine Learning Prediction of 3-Year Mortality in Patients Undergoing Percutaneous Coronary Intervention for Coronary Artery Disease

    Jul 1, 2025, 00:00

  • EPH130 Racial/Ethnic Disparities in Pneumococcal Vaccination Rates Among the Elderly: Trends and Associated Factors in the U.S., 2018-2023

    Jul 1, 2025, 00:00

  • MT26 Evaluating the Economic and Environmental Impact of Reprocessed IPC Sleeves for VTE Prophylaxis: a Cost-Consequence Analysis

    Jul 1, 2025, 00:00

  • CO63 Racial Disparities in the Burden of Illness Among Adults with Prostate Cancer in the United States

    Jul 1, 2025, 00:00

  • EE232 Economic Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D), Considering the Costs of Hospitalization Due to Heart Failure (HF) in Colombia

    Jul 1, 2025, 00:00

  • HPR37 Navigating the IRA: Impact of Medicare Part B Rebates on Drug Pricing and Manufacturer Strategies

    Jul 1, 2025, 00:00

  • HTA82 Use of Real-World Evidence in HTA Submissions and Cost-Effectiveness Evaluations in Asia

    Jul 1, 2025, 00:00

  • EE222 Budget Impact Model to Evaluate the Inclusion of a Pre-Filled Syringe Compared to Vial Application of Denosumab in Patients with Four Cancer Types in Mexico

    Jul 1, 2025, 00:00

  • PCR17 Estimating the Impact of Pill Burden on the Utility of Patients Undergoing Hemodialysis

    Jul 1, 2025, 00:00

  • HPR33 Consumption and Expenditure of WHO Essential Medicines for Cancer: Drug Utilization Analysis of 40 Countries and Regions from 2012 to 2022

    Jul 1, 2025, 00:00

  • HSD44 Cost of Depression Related Mental Healthcare for Youth During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • PT37 Operationalizing an Outcomes-Based MarketAccess Agreement Using Real-World Data From the Canadian Neuromuscular Disease Registry

    Jul 1, 2025, 00:00

  • HPR89 What Non-Profit Development of Pretomanid Can Teach About Paths to Innovation and Global Access to Treatments for Diseases of Poverty?

    Jul 1, 2025, 00:00

  • HSD82 Prisoners’ Preferences for Virtual Care Design and Delivery in the Correctional Setting: A Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • PCR8 Application of Sentiment Analysis to Aid in Evaluation of Patient Reported Outcome Measures: Analysis of Qualitative Cognitive Debriefing Interviews

    Jul 1, 2025, 00:00

  • MSR69 Emerging Trends in AI Applications: Shaping Pharmacoepidemiology and Health Technology Assessments

    Jul 1, 2025, 00:00

  • CO50 Analysis of Patient-Reported Outcomes of MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmento 12-Month Results from a Phase 2b Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE)

    Jul 1, 2025, 00:00

  • EPH56 Real-World Demographics and Clinical Characteristics of Multiple Myeloma Patients in a Colombian HMO During 2015-2023

    Jul 1, 2025, 00:00

  • EE235 Assessing Risdiplam Cost-Effectiveness for Spinal Muscular Atrophy Types I, II, and III in Chile

    Jul 1, 2025, 00:00

  • RWD166 Use of a Representative Sample of the French National Health Insurance Database (ESND) for Research: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • PCR76 Do Existing Caregiver Assessments Measure What's Important to Caregivers?

    Jul 1, 2025, 00:00

  • MSR65 Development of Robust Comprehensive Code Lists to Ensure Consistency Across Global Real-World Evidence Studies

    Jul 1, 2025, 00:00

  • MSR99 Leveraging Social Media Listening and AI: Topic Modeling and RAG Approaches to Analyse Pet Owners' Perspectives on Nonsteroidal Anti-Inflammatory Drugs in Animal Health

    Jul 1, 2025, 00:00

  • P46 Probabilistic Attribute Presentation in Discrete Choice Experiments (DCEs): A Review of Current Practice

    Jul 1, 2025, 00:00

  • PCR224 Examination of Different Segments of Health Literacy and Health Awareness Among Pregnant Women

    Jul 1, 2025, 00:00

  • HTA96 Navigating Evidence Requirements for Joint Clinical Assessment of Orphan and Advanced Therapy Medicinal Products in Europe

    Jul 1, 2025, 00:00

  • MSR68 Development of a Discrete-Time-Updating Algorithm to Predict Cannabis Use Disorder Among Arkansas Medical Marijuana Cardholders

    Jul 1, 2025, 00:00

  • HTA15 Da Vinci Robotic-Assisted Surgery: 5 years of Health Technology Assessment Trends and Recommendations

    Jul 1, 2025, 00:00

  • EE246 Estimating the Burden of Illness and Healthcare Costs Among Incident Catheter Users: A Comparison of Intermittent and Indwelling Catheter Cohorts Across Spinal Cord Injury, Multiple Sclerosis, Spina Bifida, and Benign Prostatic Hyperp ...

    Jul 1, 2025, 00:00

  • EE248 Healthcare Resource Utilization of Adult Patients with Obesity Before vs. After GLP-1 Treatment in the United States Elective Outpatient Setting

    Jul 1, 2025, 00:00

  • PCR27 Transcultural adaptation of the NutriQoL® questionnaire in American English

    Jul 1, 2025, 00:00

  • PCR97 Recurrent Patient-Reported Outcome (PRO)-Based Symptomatic Deterioration Predicts Survival and Disease Progression in Patients With Resectable Non-Small Cell Lung Cancer (NSCLC): Post-Hoc Analysis of RATIONALE-315

    Jul 1, 2025, 00:00

  • RWD16 Leveraging CMS Medicare Data for Oncology RWE: Benefits, Limitations, and Opportunities, and Insights into Enrollment Patterns

    Jul 1, 2025, 00:00

  • MT12 Patient-Centric Factors in AI Chatbot Adoption for Healthcare

    Jul 1, 2025, 00:00

  • HTA18 The Utilization of Qualitative Evidence Synthesis in Brazil’s Public Health System: A Qualitative Analysis

    Jul 1, 2025, 00:00

  • HSD51 Premature Treatment Discontinuation Among Previously Untreated Medicare Beneficiaries With Chronic Lymphocytic Leukemia Treated With Oral Targeted Therapies: A Real-World Analysis

    Jul 1, 2025, 00:00

  • EPH87 Influence of Overweight and Obesity on Disease Progression, Healthcare Utilization and Costs Among People With Prediabetes: A Cohort Study in China

    Jul 1, 2025, 00:00

  • HTA94 Investing in Clinical Guidelines to Enhance Health Technology Assessments and Reimbursement Decisions

    Jul 1, 2025, 00:00

  • EPH13 Exploring Anemia and the Underdiagnosis of Myelofibrosis: Findings From a Real-World Retrospective Cohort

    Jul 1, 2025, 00:00

  • HPR23 The Most Heavily Managed Drug Categories on Part D Formularies

    Jul 1, 2025, 00:00

  • EE365 Real-World Healthcare Resource Utilization and Economic Burden Associated With Progressive Pulmonary Fibrosis in Commercially Insured and Medicare Advantage Populations in the United States

    Jul 1, 2025, 00:00

  • EPH186 Temporal Trends in Emergency Department Utilization for Opioid Use Disorder in Baltimore, Maryland

    Jul 1, 2025, 00:00

  • RWD56 Hospitalization Risk Among Adults With Atopic Dermatitis in Brazil's Public Health System

    Jul 1, 2025, 00:00

  • RWD60 Evaluating Electronic Data Network and Direct Facility Retrieval Data Sources for Improved Patient Record Capture in Observational Studies

    Jul 1, 2025, 00:00

  • EE360 Short-Term (180-Day) Health Care Costs for Patients With Commercial or Medicare Advantage (MA) Insurance Initiating Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy for Diabetes

    Jul 1, 2025, 00:00

  • EE230 The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in Canada

    Jul 1, 2025, 00:00

  • RWD19 Persistence Patterns of Antidepressants in Mood, Anxiety, and Related Disorders: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • MSR73 Augmenting Small Training Datasets Improves Machine Learning Prognostic Performance

    Jul 1, 2025, 00:00

  • CO14 Characteristics of Patients With Bullous Pemphigoid in the US Medicare Population

    Jul 1, 2025, 00:00

  • CO41 Real-world Clinical And Demographic Characteristics Associated With Progression To Type 2 Diabetes In Patients With Prediabetes

    Jul 1, 2025, 00:00

  • EE412 The Economic Impact of Indwelling Urinary Catheterization on Total Joint Arthroplasty Procedures and Implications for Urinary Catheter Alternatives: A Systematic Review, Analysis, and Model

    Jul 1, 2025, 00:00

  • RWD93 Programmed Death Ligand 1 (PD-L1) Protein Expression Among Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma from Two Oncologic Institutions in Brazil

    Jul 1, 2025, 00:00

  • EE500 Cost-Utility Analysis of Dupilumab Versus Omalizumab in the Treatment of Severe Asthma in China

    Jul 1, 2025, 00:00

  • HTA74 Transforming Global Value Dossier (GVD) Drafting: Creation with a Generative Artificial Intelligence (Gen AI)-Driven Coauthoring Accelerator

    Jul 1, 2025, 00:00

  • PCR133 Does Providing Informal Care to Alzheimer’s Dementia Cause High Caregiver Burden: Insights From Malaysia

    Jul 1, 2025, 00:00

  • HTA50 A Reanalysis of Canada's Drug Agency (CDA) Reports: Do Conclusions from Cost-Effectiveness Analyses Using Quality-Adjusted Life-Years (QALYs) Hold When Evaluating with Equal Value of Life-Years Gained (evLYG)?

    Jul 1, 2025, 00:00

  • HSD53 The COM-IC Project: Recommendations for Core Outcome Measurement To Improve (Routine Dementia) Care Quality in Australian Aged Care Settings

    Jul 1, 2025, 00:00

  • HPR40 Determinants of FDA Review Duration for Novel Therapeutics: Analysis of Regulatory Designations and Product Characteristics

    Jul 1, 2025, 00:00

  • EPH131 Estimating US Cancer Prevalence With Community Oncology EHR-Based Datasets via National Benchmarks From SEER and NPCR

    Jul 1, 2025, 00:00

  • HPR52 Digital twins: Hype or Hope for Better Health Outcomes?

    Jul 1, 2025, 00:00

  • HPR105 Evaluation of the Cost of Treatment on Endometriosis in the Hungarian Public-Funded Healthcare System

    Jul 1, 2025, 00:00

  • SA7 Incorporating Social Drivers of Health Information Into Health Economics and Outcomes Research: Neighborhood-Level Proxies Versus Individual Level Data

    Jul 1, 2025, 00:00

  • EPH75 Development and Validation of a Machine Learning-based screening Algorithm to Predict High Risk of Hepatitis C Infection

    Jul 1, 2025, 00:00

  • PCR118 Real-World Evaluation of Trastuzumab Deruxtecan Administration, Compliance, and Dose Utilization in Chinese Patients With HER2-Positive Advanced Breast Cancer

    Jul 1, 2025, 00:00

  • EPH84 Epidemiological Insights in Cornelia-de-Lange Syndrome: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • MT7 Latent Class Analysis (LCA) to Identify Medical Device Usage in Real-World Data

    Jul 1, 2025, 00:00

  • SA13 An Assessment of Financial Burden and its Association with Desmoid Tumor Specific Symptoms and Impacts in Adult Desmoid Tumor Patients: Desmoid Tumor Research Foundation Natural History Study

    Jul 1, 2025, 00:00

  • MSR45 Explore the Prognostic Factors of Survival Outcomes in Newly Diagnosed Multiple Myeloma Who Are Not Transplant Eligible

    Jul 1, 2025, 00:00

  • HSD100 Enhanced Outcomes and Reduced Healthcare Utilization with Specialized Home Healthcare Service Providers for Ostomy and Urological Patients: Comparative Research with Pharmacy-Based Care

    Jul 1, 2025, 00:00

  • HTA33 Streamlined Success or Missed Opportunity: Evaluating the Impact of Simplified Economic Approaches on HTA Recommendations Across CDA-AMC, INESSS and NICE

    Jul 1, 2025, 00:00

  • EE209 Non-Invasive Tests (NITs) to Risk-Stratify Patients with Noncirrhotic Metabolic-Associated Steatohepatitis (MASH) in a Specialty Setting Eligible for Resmetirom: A Cost-Effectiveness Analysis from a U.S. Payer Perspective

    Jul 1, 2025, 00:00

  • CO87 Association Between Vaginal Progesterone Use and Risk of Preterm Birth Among High-Risk Pregnancies: A Real-World Evidence Study

    Jul 1, 2025, 00:00

  • HSD24 Patient Characteristics Associated with the Use of Newly Approved Disease-Modifying Therapy (DMT) for Sickle Cell Disease in Texas Medicaid

    Jul 1, 2025, 00:00

  • PCR19 The Unseen Progress: How PROs May Overlook the Value of Slowing Degenerative Decline

    Jul 1, 2025, 00:00

  • EE420 Compare the Return on Investment of Pulsed Field Ablation With Conventional Thermal Ablation for Treatment of Atrial Fibrillation in China

    Jul 1, 2025, 00:00

  • HTA83 Enhancing Health Technology Assessment With Data Transportability Analyses: Addressing Bias and Generalizability Challenges In Non-Local Real-World Evidence

    Jul 1, 2025, 00:00

  • MSR125 Methodology for Estimating Equal Value Life-Year for Standard Three-State Partitioned Survival Models

    Jul 1, 2025, 00:00

  • HPR47 Impacts of the Inflation Reduction Act on 2025 Formulary Coverage in Medicare Part D Plans

    Jul 1, 2025, 00:00

  • EPH150 Microbiology Testing and Oral Antibiotic Treatment Among CKD Patients With Urinary Tract Infections: Real-World Evidence From a US EMR Network

    Jul 1, 2025, 00:00

  • EE516 Cost-Effectiveness Analysis of Adjuvant Pembrolizumab Versus Standard-of-Care (SOC) Immunotherapies (High-Dose interferon Alfa 2-b or Ipilimumab) in High-Risk Resected Melanoma in United States (US)

    Jul 1, 2025, 00:00

  • HSD19 Estimating Costs Of Dispensing Services In Community Pharmacies In Taiwan Using A Time-Driven Activity-Based Costing Approach

    Jul 1, 2025, 00:00

  • PCR210 Association Between Caregiver Quality of Life and the Care Provided to Adults With Severe Visual Impairments: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • EE294 Economic Burden of Avoidable Blindness Due to Diabetic Macular Edema in Ecuador

    Jul 1, 2025, 00:00

  • RWD49 Development and Application of a Novel Framework for Clinician Stakeholder Engagement in Real-world Data (RWD) Studies

    Jul 1, 2025, 00:00

  • EE410 Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Chronic Lymphocytic Leukemia Treated with Fixed Duration Therapy in a First-Line Setting in Alberta, Canada

    Jul 1, 2025, 00:00

  • PCR99 Mapping between the HUI2/HUI3 and the PROPr in the United States

    Jul 1, 2025, 00:00

  • PCR9 Empowering Patients in Observational Research: Leveraging Data Insights for Sustained Engagement and Innovation

    Jul 1, 2025, 00:00

  • EE338 Avoidable Costs by the Inclusion Ff Finerenone in Terms of Hospitalization Due to Heart Failure (HF) and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia

    Jul 1, 2025, 00:00

  • PCR128 Validation of a Questionnaire to Evaluate Simplicity of Diabetes Treatment (SIM-Q)

    Jul 1, 2025, 00:00

  • HTA26 The Impact of CDA-AMC Sequential Analysis on Decision-Making in Oncology

    Jul 1, 2025, 00:00

  • CO34 Real-World Cancer Recurrence and Overall Survival Outcomes in Muscle-Invasive Bladder Cancer (MIBC) Patients Treated With Radical Cystectomy (RC): A Retrospective Surveillance, Epidemiology, and End Results-Medicare Study

    Jul 1, 2025, 00:00

  • HTA12 Navigating Uncertainty in Overall Survival Data: Insights from Positive Canadian HTAs on Lung Cancer Therapies

    Jul 1, 2025, 00:00

  • HPR64 ICER Thresholds in Cost-Utility Analysis: Assessing Conceptual Relevance and Practical Adequacy for Drug Reimbursement Decision-Making in The US

    Jul 1, 2025, 00:00

  • PCR21 Health-Related Quality of Life and Associated Factors Among Patients With Chronic Diseases in Hainan Province, China

    Jul 1, 2025, 00:00

  • PCR31 The Impact of Mucopolysaccharidosis Type III (MPS III) on Family and Finances: A Caregiver Perspective

    Jul 1, 2025, 00:00

  • HPR42 The Emerging Potential of International Reference Pricing (IRP) in the US: An Analysis of Trends, Challenges, Opportunities and learnings from Europe

    Jul 1, 2025, 00:00

  • HPR27 US Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics, 1980–2024

    Jul 1, 2025, 00:00

  • HSD49 Diagnosis and Treatment Journey of Patients With Atrial Fibrillation Prior to Stroke Occurrence

    Jul 1, 2025, 00:00

  • CO56 Comparison of Selective Serotonin Reuptake Inhibitors and USA Food and Drug Administration-Approved Serotonin-Norepinephrine Reuptake Inhibitors Treatments for Fibromyalgia: A Systematic Review and Network Meta-Analysis

    Jul 1, 2025, 00:00

  • EE489 Costs of Initiated Potentially Inappropriate Medication in 2021-2022 in Quebec, Canada

    Jul 1, 2025, 00:00

  • EE479 Modeling in R: Tutorial for Beginner Using a Cost-Effectiveness Analysis Made With Microsoft Excel

    Jul 1, 2025, 00:00

  • MSR140 Adapting PRISMA For System Dynamics Models In Healthcare: A Case Study Of Transcatheter Aortic Valve Implantation In Canada

    Jul 1, 2025, 00:00

  • EE431 Healthcare Costs and Resource Use in Patients With Sjögren's Syndrome (SS): A Systematic Literature Review of Real-World Evidence (RWE) Studies

    Jul 1, 2025, 00:00

  • EPH178 Estimates of the Public Health Impact of Norovirus Vaccination for Older Adults in the United States

    Jul 1, 2025, 00:00

  • HPR107 Trends in Breast Cancer Drugs Approved by the US Food and Drug Administration, 1980-2024

    Jul 1, 2025, 00:00

  • EE210 Nirsevimab for RSV Prevention in Hong Kong Infants: A Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • HTA90 Economic Impact of Implementing a Clinical Protocol and Therapeutic Guidelines for Cow's Milk Protein Allergy in Two States of Brazil

    Jul 1, 2025, 00:00

  • EPH187 Association of Sleep Disturbances With Mild Cognitive Impairment Among Adults in the US

    Jul 1, 2025, 00:00

  • HPR57 Comparing the Social and Private Value Created by Pembrolizumab 2014-2022

    Jul 1, 2025, 00:00

  • EE510 An Economic Model to Evaluate the Impact of Formulary Tier Increases for Apixaban on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation in the United States

    Jul 1, 2025, 00:00

  • MT15 RtCGM Use is Associated with Improved Glycemic Control Compared to isCGM in Commercially Insured People with Type 2 Diabetes on Semaglutide and Insulin

    Jul 1, 2025, 00:00

  • EE327 Belantamab Mafodotin, Pomalidomide, and Dexamethasone (BPd) in Relapsed/Refractory Multiple Myeloma (RRMM): Quality-Adjusted Life-Year (QALY) Results From a Cost-Effectiveness Model

    Jul 1, 2025, 00:00

  • HPR171 Comparison of Therapeutic Efficacy by Disease for Outpatients Using Herbal Decoctions Based on the Using the Usage and Consumption of Korean Medicine Report in 2020

    Jul 1, 2025, 00:00

  • PCR219 Quality-of-Life, Symptom Burden, and Tolerability in Frail Patients without Caregivers in Real-world Oncology Practice

    Jul 1, 2025, 00:00

  • EE346 The Clinical Value and Cost-Effectiveness of DefenCath for Reducing Catheter-Related Bloodstream Infections in Adult Patients Receiving Hemodialysis Through a Central Venous Catheter

    Jul 1, 2025, 00:00

  • RWD82 Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients With Bipolar I Disorder

    Jul 1, 2025, 00:00

  • PCR237 Evaluating Thresholds for Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures (PROMs) in Locally Advanced or Metastatic Urothelial Cancer (la/mUC): a Systematic Literature Review (SLR)

    Jul 1, 2025, 00:00

  • PCR241 Beyond Overall Survival: Advancing the Understanding and Use of Surrogate Endpoints in Oncology

    Jul 1, 2025, 00:00

  • Reviewer Acknowledgment

    Jul 1, 2025, 00:00

  • PT19 Timing of Health Technology Assessment in the United States: An Evaluation of ICER Reviews Over Seven Years

    Jul 1, 2025, 00:00

  • P32 Oncology Trial Emulation Using Real-World Electronic Health Record Data: Results of the Coalition to Advance Real-World Evidence Through Randomized Controlled Trial Emulation (CARE) Initiative

    Jul 1, 2025, 00:00

  • EE299 Cost Per PFS-Based Responder for TKI-Naive Patients Receiving Repotrectinib or Entrectinib in ROS1 Fusion Positive Non-Small Cell Lung Cancer (NSCLC) in the United States (US)

    Jul 1, 2025, 00:00

  • RWD151 Real-World Evidence on the Use of Secondary Prevention for People With ASCVD or CKD: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR253 Psychometric Evaluation of the ASCOT-SCT4, a Preference-Based Quality of Life Instrument for Social Care Service Users in Hong Kong: An Application of Item Response Theory

    Jul 1, 2025, 00:00

  • PCR93 Beyond Clinical Data: Assessing Usage Patterns of Real-World Home-Reported Outcomes To Capture the Full Burden of Atopic Dermatitis Symptoms and Flares

    Jul 1, 2025, 00:00

  • CO1 Assessment of Disease Progression and Healthcare Resource Utilization Associated with Duchenne Muscular Dystrophy: A Retrospective Observational Study Using the Optum Market Clarity Database

    Jul 1, 2025, 00:00

  • P27 Use of Metamodels in Health Economics to Bypass Complexity and Democratize Modeling

    Jul 1, 2025, 00:00

  • EPH48 Variables Statistically Associated With Mental Health Among United States Adults With Asthma in the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • EE324 Cost Analysis of Surgical Treatment for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Refractory to Clinical Therapy in Brazil

    Jul 1, 2025, 00:00

  • EE443 Costs Avoided by the Inclusion of Finerenone Based on Hospitalization and Death Due to Cardiovascular Events and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia

    Jul 1, 2025, 00:00

  • Editorial Board

    Jun 3, 2025, 09:22

  • Costs and Health Outcomes in Economic Evaluations of Person-Centered Care: A Systematic Review

    Jun 1, 2025, 00:00

  • Use of Real-World Evidence in Health Technology Reassessments Across 6 Health Technology Assessment Agencies

    Jun 1, 2025, 00:00

  • Why Is Distributional Cost-Effectiveness Analysis Not Ready for Prime Time in Health Technology Assessment?

    Jun 1, 2025, 00:00

  • Understanding the Economic Value of Interventions Addressing Perinatal Mental Health Problems: A Literature Review and Methodological Considerations

    Jun 1, 2025, 00:00

  • Quantifying Low-Value Care in Germany: An Observational Study Using Statutory Health Insurance Data From 2018 to 2021

    Jun 1, 2025, 00:00

  • The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level

    Jun 1, 2025, 00:00

  • Economic Evaluation of Internet-Based Psychological Interventions: A Scoping Review of Methodological Choices

    Jun 1, 2025, 00:00

  • US Drug Pricing Patterns Before Loss of Exclusivity

    Jun 1, 2025, 00:00

  • When Do Value-Based Contracts Add Value? Insights From Probabilistic Simulations

    Jun 1, 2025, 00:00

  • The Value of Positron Emission Tomography for Confirmation of Alzheimer’s Disease in the Era of Amyloid-Targeting Therapies

    Jun 1, 2025, 00:00

  • Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report

    Jun 1, 2025, 00:00

  • Table of Contents

    Jun 1, 2025, 00:00

  • Quality-Adjusted Life Expectancy by Socioeconomic Disadvantage and Remoteness Area: Population Norms for Australia

    Jun 1, 2025, 00:00

  • A Person-Centered eHealth Intervention for Patients With Common Mental Disorders: Cost-Effectiveness Analysis Within a Randomized Controlled Trial

    Jun 1, 2025, 00:00

  • A Factual Inaccuracy Noted in the Conclusions Specifically Regarding the Novelty of the Author’s Work in the Middle East

    Jun 1, 2025, 00:00

  • Performance of the EQ-5D-5L With Skin Irritation and Self-Confidence Bolt-On Items in Patients With Urticaria

    Jun 1, 2025, 00:00

  • Can Adolescents Value the EQ-5D-Y-5L and EQ-5D-5L, and How Do the Values Compare? A Feasibility Study

    Jun 1, 2025, 00:00

  • Drop the “M”: Minimally Important Difference and Change Are Not Independent Properties of an Instrument and Cannot Be Determined as a Single Value Using Statistical Methods

    Jun 1, 2025, 00:00

  • The Health Inequality Impact of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2025, 00:00

  • Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations

    Jun 1, 2025, 00:00

  • A Managed Access Protocol for Liraglutide for Weight Management: A Retrospective, Observational Study in Ireland

    Jun 1, 2025, 00:00

  • Editorial Board

    May 7, 2025, 15:10

  • Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases

    May 1, 2025, 00:00

  • Are Updated COVID-19 Vaccines Still Relevant for All Adult Age Groups? An Economic Evaluation of the Monovalent XBB.1.5 Vaccine in Australia

    May 1, 2025, 00:00

  • Do Machine Learning Approaches Perform Better Than Regression Models in Mapping Studies? A Systematic Review

    May 1, 2025, 00:00

  • A Comparison of International Modeling Methods for Evaluating Health Economics of Colorectal Cancer Screening: A Systematic Review

    May 1, 2025, 00:00

  • How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report

    May 1, 2025, 00:00

  • Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer

    May 1, 2025, 00:00

  • Development and Testing of the Psychometric Properties of 20 Bolt-On Items for the EQ-5D-5L Across 31 Rare Diseases

    May 1, 2025, 00:00

  • Table of Contents

    May 1, 2025, 00:00

  • Public Health Supports Whole Health

    May 1, 2025, 00:00

  • What Does "Whole Health" Really Mean for Health Economics and Outcomes Research?

    May 1, 2025, 00:00

  • Whole Health: A Global Perspective

    May 1, 2025, 00:00

  • Rare Disease Policy in High-Income Countries: An Overview of Achievements, Challenges, and Solutions

    May 1, 2025, 00:00

  • Newer Glucagon-Like Peptide-1 Receptor Agonists Are Associated With Improved Glycemic Control in US Adults With Type 2 Diabetes: A Population-Level Time Series Analysis

    May 1, 2025, 00:00

  • Capturing the Additional Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists Beyond the Control of Traditional Risk Factors in People With Diabetes

    May 1, 2025, 00:00

  • The Price Effects of Biosimilars in the United States

    May 1, 2025, 00:00

  • An Acquired Taste: Latent Class Analysis to Compare Adolescent and Adult Preferences for EQ-5D-Y-3L Health States

    May 1, 2025, 00:00

  • Managing Uncomplicated Singleton Breech Pregnancy Using the OptiBreech Collaborative Care Pathway: Early Economic Model and Value of Information Analysis

    May 1, 2025, 00:00

  • Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report

    May 1, 2025, 00:00

  • Taking Health Economics and Outcomes Research Forward: Expanding the Definition of Value to Include Whole Health

    May 1, 2025, 00:00

  • Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products

    May 1, 2025, 00:00

  • IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer’s Disease

    Apr 1, 2025, 00:00

  • Exploring a Patient-Centered Methodology to Identify Suitable Proxy Conditions as a Source for Utility Data, Using Alopecia Areata as a Case Example

    Apr 1, 2025, 00:00

  • Role of Health Equity in Health Technology Assessment Processes: A Landscape Analysis of 13 Health Systems in Asia

    Apr 1, 2025, 00:00

  • Cost-Effectiveness of a Digitally Supported Care Management Program for Caregivers of People With Dementia

    Apr 1, 2025, 00:00

  • The Application of Time-Driven Activity-Based Costing in Oncology: A Systematic Review

    Apr 1, 2025, 00:00

  • The Health Economics of Alzheimer’s Disease and Related Dementias

    Apr 1, 2025, 00:00

  • A United Kingdom Value Set for the Weight-Specific Adolescent Instrument for Economic Evaluation

    Apr 1, 2025, 00:00

  • How Do Individuals Value Worse-Than-Dead EQ-5D-5L Health States in Composite Time Trade-Off Tasks? A Qualitative Study

    Apr 1, 2025, 00:00

  • A Value Set for EQ-5D-5L in the United Arab Emirates

    Apr 1, 2025, 00:00

  • How Do Bundled Payment Initiatives Account for Differences in Patient Risk Profiles? A Systematic Review

    Apr 1, 2025, 00:00

  • Indirect Costs of Alzheimer’s Disease: Unpaid Caregiver Burden and Patient Productivity Loss

    Apr 1, 2025, 00:00

  • New IPECAD Open-Source Model Framework for the Health Technology Assessment of Early Alzheimer’s Disease Treatment: Development and Use Cases

    Apr 1, 2025, 00:00

  • Using Outcome Information During Consultation Yields Better Shared Decision Making, Better Patient Experiences, and More Positive Expectations: A Comparative Effectiveness Study

    Apr 1, 2025, 00:00

  • A Comparison of the Performance of 6 Surrogacy Models, Including Weighted Linear Regression, Meta-Regression, and Bivariate Meta-Analysis

    Apr 1, 2025, 00:00

  • Reviewer Acknowledgment

    Apr 1, 2025, 00:00

  • Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study

    Apr 1, 2025, 00:00

  • Table of Contents

    Apr 1, 2025, 00:00

  • Age and Gender Differences in the Relationship Between Chronic Pain and Dementia Among Older Australians

    Apr 1, 2025, 00:00

  • A New Approach for Assessing the Value of Informal Care in Alzheimer’s Disease

    Apr 1, 2025, 00:00

  • The Excess Direct Social Costs of Dementia-Related Neuropsychiatric Symptoms: A Regionwide Cohort Study Beyond Silos

    Apr 1, 2025, 00:00

  • Editorial Board

    Mar 26, 2025, 10:50

  • The Impact of Chronic Conditions on Productivity-Adjusted Life-Years in Both the Workplace and Household Settings in the General Adult Population in Finland

    Mar 1, 2025, 00:00

  • Maternal Mental Health Spillovers From Child Illness and Disability: A Dynamic Panel Analysis

    Mar 1, 2025, 00:00

  • Economic Considerations in Designs and Modifications of Multiarm, Multistage Adaptive and Adaptive Platform Randomized Controlled Trials: A Systematic Literature Review

    Mar 1, 2025, 00:00

  • Social Return on Investment Analysis: A Mixed Methods Approach to Assessing the Value of Adult Hospice Services

    Mar 1, 2025, 00:00

  • Prevalence of Immature Survival Data for Anticancer Drugs Presented to the National Institute for Health and Care Excellence Between 2018 and 2022

    Mar 1, 2025, 00:00

  • The Psychometric Properties of the EQ-HWB and EQ-HWB-S in Patients With Breast Cancer: A Comparative Analysis With EQ-5D-5L, FACT-8D, and SWEMWBS

    Mar 1, 2025, 00:00

  • The Estimation of Health State Utility Values for Psychological Distress in Australia: Implications for Future Economic Evaluations

    Mar 1, 2025, 00:00

  • Evaluating the Health and Economic Impacts of Return-to-Work Interventions: A Modeling Study

    Mar 1, 2025, 00:00

  • Estimating the Lifetime Costs and Benefits of the Incredible Years Teacher Classroom Management Intervention Using Data From 30 Months Follow-Up of the Supporting Teachers and childRen in Schools Trial

    Mar 1, 2025, 00:00

  • Estimating the Economic Impacts for Caregivers of Young People With Mental Health Problems in a Brazilian Cohort

    Mar 1, 2025, 00:00

  • The Feasibility of Personalized Endpoints in Assessing Treatment Outcomes for Rare Diseases: A Pilot Study of Goal Attainment Scaling in SCN2A-Associated Developmental Epileptic Encephalopathy

    Mar 1, 2025, 00:00

  • Cost-Utility Analysis of Antipsychotic Reduction and Discontinuation in Patients With Long-Term Schizophrenia and Psychosis in English Mental Health Trusts: The RADAR Study

    Mar 1, 2025, 00:00

  • Table of Contents

    Mar 1, 2025, 00:00

  • Does Regulatory and Reimbursement Parallel Processing Provide Swifter Funded Access to Medicines for Patients? Evaluation of Cancer Medicines Using the Australian Parallel Process

    Mar 1, 2025, 00:00

  • Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis

    Mar 1, 2025, 00:00

  • Advancing Mental Health Economics: Insights From the Themed Section

    Mar 1, 2025, 00:00

  • Developing an Australian Value Set for the Recovering Quality of Life-Utility Index Instrument Using Discrete Choice Experiment With Duration

    Mar 1, 2025, 00:00

  • A Systematic Literature Review of Important and Meaningful Differences in the EQ-5D Index and Visual Analog Scale Scores

    Mar 1, 2025, 00:00

  • Economic Evaluation of 9 Intersectoral Strategies to Improve Youth Mental Health and Alleviate Financial Burden in Colombia Using System Dynamics Modeling

    Mar 1, 2025, 00:00

  • Editorial Board

    Feb 26, 2025, 12:14

  • The Influence of Recall and Timing of Assessment on the Estimation of Quality-Adjusted Life-Years When Health Fluctuates Recurrently

    Feb 1, 2025, 00:00

  • Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations: An ISPOR Working Group Report

    Feb 1, 2025, 00:00
  • 1
  • 2
  • 3
  • 4 (current)
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »